Use of histogranin and histogranin-like compounds as...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 7/08 (2006.01) A61K 31/05 (2006.01) A61K 31/4184 (2006.01) A61K 38/05 (2006.01) A61K 38/06 (2006.01) A61K 38/08 (2006.01) A61K 38/10 (2006.01) A61K 38/12 (2006.01) A61P 19/02 (2006.01) A61P 25/28 (2006.01) A61P 29/00 (2006.01) C07K 5/00 (2006.01) C07K 7/06 (2006.01) C12Q 1/02 (2006.01) G01N 33/566 (2006.01)

Patent

CA 2625940

The invention relates to the use of Histogranin-like compounds to reduce P2X7( also designed P2Z) receptor function. The invention also provides a method for the prevention and treatment of rheumatoid arthritis and a variety of diseases/disorders including inflammatory disorders and neurodegenerative diseases.

L'invention concerne l'utilisation de composés du type histogranine destinés à réduire la fonction du récepteur P2X7 (désigné également par P2Z). L'invention se rapporte également à un procédé permettant de prévenir et traiter l'arthrite rhumatoïde et une variété de maladies/troubles, parmi lesquels les troubles inflammatoires et les maladies neurodégénératives.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of histogranin and histogranin-like compounds as... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of histogranin and histogranin-like compounds as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of histogranin and histogranin-like compounds as... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1575536

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.